# The Study of NPC-06 - Investigation of Safety, Efficacy and Pharmacokinetics of Fosphenytoin

> **NCT00908453** · PHASE3 · COMPLETED · sponsor: **Nobelpharma** · enrollment: 40 (estimated)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** fosphenytoin

## Key facts

- **NCT ID:** NCT00908453
- **Lead sponsor:** Nobelpharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2010-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00908453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00908453, "The Study of NPC-06 - Investigation of Safety, Efficacy and Pharmacokinetics of Fosphenytoin". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00908453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*